Article Details

Connect BioPharma Successfully Completes CBP-174 Phase 1 - GlobeNewswire

Retrieved on: 2022-08-30 12:04:27

Tags for this article:

Click the tags to see associated articles and topics

Connect BioPharma Successfully Completes CBP-174 Phase 1 - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/08/30/2506696/0/en/Connect-BioPharma-Successfully-Completes-CBP-174-Phase-1-Single-Ascending-Dose-Study.html

Excerpt

SAN DIEGO and TAICANG, SUZHOU, China, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up